PharmaShots | Incisive News in 3 Shots

Subscribe Now

Iovance Biotherapeutics

The US FDA Puts Clinical Hold on Iovance Biotherapeutics’ (IOV-LUN-202) Trial of LN-145 for Non-Small Cell Lung Cancer

The US FDA Puts Clinical Hold on Iovance Biotherapeutics’ (IOV-LUN-202) Trial of LN-145 for Non-Small Cell Lung Cancer

January 1, 2024

Iovance Biotherapeutics Reports the First Patient Randomizing of Lifileucel in P-III Trial (TILVANCE-301) for Frontline Advanced Melanoma

Iovance Biotherapeutics Reports the First Patient Randomizing of Lifileucel in P-III Trial (TILVANCE-301) for Frontline Advanced M...

June 15, 2023

Iovance Biotherapeutics Reports the US FDA Acceptance of BLA for Lifileucel to Treat Advanced Melanoma

Iovance Biotherapeutics Reports the US FDA Acceptance of BLA for Lifileucel to Treat Advanced Melanoma

May 30, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us